We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-4.8%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$6.53B
AUM Growth
-$743M
Cap. Flow
-$221M
Cap. Flow %
-3.38%
Top 10 Hldgs %
12.1%
Holding
647
New
71
Increased
143
Reduced
319
Closed
74

Top Buys

Rank Stock Value
1
SYNA icon
Synaptics
SYNA
+$36.2M
2
ALGM icon
Allegro MicroSystems
ALGM
+$32.7M
3
AMBA icon
Ambarella
AMBA
+$21.2M
4
ATR icon
AptarGroup
ATR
+$20.4M
5
FIVN icon
FIVE9
FIVN
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 18.14%
2 Industrials 17.3%
3 Financials 15.66%
4 Healthcare 14.96%
5 Consumer Discretionary 11.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBR icon
526
Petrobras
PBR
$123B
$718K 0.01%
50,100
ATLC icon
527
Atlanticus Holdings
ATLC
$1.63B
$696K 0.01%
+13,598
New +$742K
GSSC icon
528
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.08B
$693K 0.01%
10,921
-79
-0.7% -$5.38K
GLPI icon
529
Gaming and Leisure Properties
GLPI
$12.7B
$686K 0.01%
13,474
HFFG icon
530
HF Foods Group
HFFG
$79.7M
$681K 0.01%
+139,030
New +$380K
COLL icon
531
Collegium Pharmaceutical
COLL
$1.15B
$672K 0.01%
22,515
-16,468
-42% -$503K
INVA icon
532
Innoviva
INVA
$1.53B
$668K 0.01%
36,867
CZFS icon
533
Citizens Financial Services
CZFS
$368M
$661K 0.01%
+11,499
New +$685K
RIGL icon
534
Rigel Pharmaceuticals
RIGL
$693M
$648K 0.01%
36,001
-258
-0.7% -$5.23K
KVUE icon
535
Kenvue
KVUE
$37.5B
$644K 0.01%
26,870
+4,582
+21% +$101K
NL icon
536
NLI Holdings
NL
$289M
$644K 0.01%
+81,495
New +$607K
MYGN icon
537
Myriad Genetics
MYGN
$289M
$640K 0.01%
72,117
VALE icon
538
Vale
VALE
$63.1B
$637K 0.01%
63,874
-44,900
-41% -$424K
ATNI icon
539
ATN International
ATNI
$379M
$632K 0.01%
+31,121
New +$558K
AMPY icon
540
Amplify Energy
AMPY
$166M
$632K 0.01%
168,915
-1,402
-0.8% -$6.99K
WIT icon
541
Wipro
WIT
$20.3B
$619K 0.01%
202,200
RDY icon
542
Dr. Reddy's Laboratories
RDY
$10.1B
$595K 0.01%
45,100
HMY icon
543
Harmony Gold Mining
HMY
$10.3B
$588K 0.01%
39,800
+2,700
+7% +$30.1K
CG icon
544
Carlyle Group
CG
$18.2B
$567K 0.01%
13,000
ADM icon
545
Archer Daniels Midland
ADM
$37.6B
$562K 0.01%
11,700
VTEB icon
546
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
$550K 0.01%
+11,090
New +$555K
RSPT icon
547
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.87B
$547K 0.01%
16,000
ACCO icon
548
Acco Brands
ACCO
$399M
$543K 0.01%
+129,602
New +$636K
AB icon
549
AllianceBernstein
AB
$3.46B
$540K 0.01%
14,100
VRP icon
550
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$504K 0.01%
20,795
-1,125
-5% -$27.4K

Similar funds

Segall Bryant & Hamill's Q1 2025 Portfolio in Review

As of Q1 2025, Segall Bryant & Hamill held 647 positions worth $6.53B, down 10% from $7.27B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill withdrew a net $221M in Q1 2025, closing 74 positions and reducing 319 holdings. Its most notable exit was Summit Materials, Inc. Class A Common Stock, an estimated $77.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

Against the trend, Segall Bryant & Hamill opened a new position in Synaptics worth $31.8M.

  • Segall Bryant & Hamill's largest Q1 2025 buy was Synaptics: 499,078 shares worth $31.8M.
  • Segall Bryant & Hamill added most to FIVE9 in Q1 2025, an estimated $20.1M increase.
  • Segall Bryant & Hamill's biggest Q1 2025 reduction was VF Corp, cutting an estimated $27.5M.
  • Segall Bryant & Hamill fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $77.1M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $6.53B portfolio in Q1 2025.
  • Segall Bryant & Hamill opened 71 new positions and closed 74 in Q1 2025.
  • Segall Bryant & Hamill's portfolio value fell 10% quarter-over-quarter to $6.53B.

Based on Segall Bryant & Hamill's 13F filing for Q1 2025, filed 2 May 2025.